Search

Your search keyword '"Le Voyer, T."' showing total 79 results

Search Constraints

Start Over You searched for: Author "Le Voyer, T." Remove constraint Author: "Le Voyer, T."
79 results on '"Le Voyer, T."'

Search Results

1. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

2. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

3. X-linked recessive TLR7 deficiency in similar to 1% of men under 60 years old with life-threatening COVID-19

4. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

5. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

6. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

7. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

8. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

9. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

15. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

16. Human genetic and immunological determinants of critical COVID-19 pneumonia

17. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

18. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

19. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

20. Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

21. Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients.

22. IL-7-dependent and -independent lineages of IL-7R-dependent human T cells.

23. A sensitive assay for measuring whole-blood responses to type I IFNs.

24. Inherited human RelB deficiency impairs innate and adaptive immunity to infection.

25. Tuberculosis in otherwise healthy adults with inherited TNF deficiency.

26. Human inherited CCR2 deficiency underlies progressive polycystic lung disease.

27. Correction: Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.

28. Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.

29. Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency.

30. Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.

31. The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants.

32. Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.

33. Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency.

34. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.

35. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

36. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

37. Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.

38. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.

39. Atypical Cutaneous Viral Infections Reveal an Inborn Error of Immunity in 8 Patients.

40. Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria.

41. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.

42. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.

43. Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.

44. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.

45. Autoantibodies against type I IFNs in patients with critical influenza pneumonia.

46. Chronic Granulomatous Disease-Like Presentation of a Child with Autosomal Recessive PKCδ Deficiency.

47. Pulmonary Alveolar Proteinosis and Multiple Infectious Diseases in a Child with Autosomal Recessive Complete IRF8 Deficiency.

48. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.

49. A partial form of inherited human USP18 deficiency underlies infection and inflammation.

50. JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.

Catalog

Books, media, physical & digital resources